E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/30/2006 in the Prospect News Biotech Daily.

Jefferies ups ICON price target

ICON plc was reiterated at a buy with an increased price target of $42 by Jefferies & Co., Inc. analyst David Windley on news of the company's backlog of $815 million and net bookings up 29% year over year. Windley estimates revenue growth of about 20% and earnings per share growth of about 30% in calendar year 2007. ICON reported earnings per share of $0.35 on $120.7 million in revenue, compared with Jefferies' estimate of $0.33 on $109.9 million and consensus of $0.34 on $109.6 million. Shares of the Dublin, Ireland-based contract research organization were up 4 cents, or 0.11%, at $35.99. (Nasdaq: ICLR)


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.